Free Trial

BioLargo Q4 2023 Earnings Report

BioLargo logo
$0.28 +0.00 (+0.36%)
As of 03/28/2025 03:57 PM Eastern

BioLargo EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioLargo Revenue Results

Actual Revenue
$4.37 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioLargo Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Remove Ads

BioLargo Earnings Headlines

Alert: DOGE goes live
Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest economic transformation in American history. See, there's one particular part of Elon and Trump's plans that you need to pay special attention to right now.
BioLargo (OTC: BLGO)
BioLargo provides 2025 corporate outlook
See More BioLargo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioLargo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioLargo and other key companies, straight to your email.

About BioLargo

BioLargo (NASDAQ:BLGO) invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

View BioLargo Profile

More Earnings Resources from MarketBeat